Cardio Diagnostics
CDIO
10 hedge funds and large institutions have $445K invested in Cardio Diagnostics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.01% more ownership
Funds ownership: 0.12% → 0.12% (+0.01%)
9% less funds holding
Funds holding: 11 → 10 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
66% less capital invested
Capital invested by funds: $1.31M → $445K (-$864K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
+$207K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.01K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$6.15K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$75.4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$58.6K |
| 3 |
State Street
Boston,
Massachusetts
|
-$40.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Prelude Capital Management
New York
| $131K | +$207K | +3,667 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $89.8K | +$2.26K | +40 | +2% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $76.2K | – | – | – |
|
|
LA
4
Linden Advisors
New York
| $54.3K | -$75.4K | -1,336 | -47% |
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $48.2K | – | – | – |
|
|
6
State Street
Boston,
Massachusetts
| $23.9K | -$40.6K | -720 | -52% |
|
|
CSC
7
Caldwell Sutter Capital
Sausalito,
California
| $9.64K | – | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $6.6K | +$8.01K | +142 | +330% |
|
|
WAM
9
Wolverine Asset Management
Chicago,
Illinois
| $5.7K | +$6.15K | +109 | +214% |
|
10
Wells Fargo
San Francisco,
California
| $52 | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$58.6K | -500 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$10.5K | -89 | Closed |
|
CDIO Hedge Fund Activity: Q2 2023 in Review
10 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q2 2023, worth a combined $445K — down 66% from $1.31M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CDIO and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Prelude Capital Management, opening a new position worth an estimated $207K. The largest seller was Linden Advisors, cutting an estimated $75.4K.
- 10 institutional investors held Cardio Diagnostics (CDIO) as of Q2 2023, down from 11 in Q1 2023.
- Funds reported $445K of Cardio Diagnostics stock for Q2 2023, down 66% quarter-over-quarter.
- 1 fund opened new Cardio Diagnostics positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest Cardio Diagnostics buyer in Q2 2023 was Prelude Capital Management, an estimated $207K added.
- The largest Cardio Diagnostics seller in Q2 2023 was Linden Advisors, an estimated $75.4K sold.
Based on aggregated 13F filings for Q2 2023.